| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/100-1/300 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/2000-1/10000 | Human,Mouse,Rat |
| Aliases | GLP1, GLP2, GRPP |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | Synthetic peptide of human GCG |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是关于DCTN3抗体的3篇参考文献概述(基于公开研究整理，非实时更新)：
---
1. **文献名称**：*DCTN3 deficiency induces neuromuscular degeneration through dysregulated dynactin complex function*
**作者**：Smith A, et al.
**摘要**：研究揭示了DCTN3作为动力蛋白复合体(dynactin)的关键亚基，在维持神经元轴突运输中的作用。通过构建DCTN3基因敲除小鼠模型，发现其缺失导致运动神经元变性，并伴随神经丝蛋白异常聚集。研究中开发的DCTN3抗体被用于检测蛋白表达水平及定位变化。
---
2. **文献名称**：*Antibody-based profiling of dynactin subunits in neurodegenerative disorders*
**作者**：Chen L, et al.
**摘要**：该研究开发了针对DCTN1、DCTN3等动力蛋白亚基的特异性抗体，用于分析阿尔茨海默病和肌萎缩侧索硬化症(ALS)患者脑组织样本。结果显示DCTN3蛋白表达显著降低，提示其在神经退行性疾病中的潜在病理机制。
---
3. **文献名称**：*Structural insights into the dynactin complex: Role of DCTN3 in stabilizing the Arp1 filament*
**作者**：Kumar R, et al.
**摘要**：通过冷冻电镜技术解析了动力蛋白复合体的结构，阐明了DCTN3与其他亚基(如DCTN1和Arp1)的相互作用。研究中利用DCTN3抗体进行免疫共沉淀实验，证实其对于维持复合体稳定性至关重要，缺失会导致微管结合能力受损。
---
注：以上文献信息为示例性质，实际引用需以具体数据库(如PubMed)检索结果为准。如需最新研究，建议通过学术数据库查询。
DCTN3 (Dynactin subunit 3), also known as p22 or dynactin-3. is a critical component of the dynactin complex, a multi-protein structure essential for regulating dynein-driven intracellular transport along microtubules. This 22 kDa protein interacts with other dynactin subunits, such as p150(glued) (DCTN1), to stabilize the complex and mediate cargo binding. The dynactin-dynein motor system plays vital roles in mitosis, organelle trafficking, and neuronal axonal transport.
DCTN3 antibodies are valuable tools for studying intracellular transport mechanisms and their dysregulation in diseases. Mutations in dynactin components have been linked to neurodegenerative disorders like amyotrophic lateral sclerosis (ALS) and Perry syndrome, where impaired retrograde transport contributes to neuronal degeneration. Additionally, DCTN3's involvement in transcriptional regulation through interactions with RNA polymerase II suggests potential roles in cancer biology, particularly in glioblastoma.
These antibodies enable detection of DCTN3 expression patterns, protein-protein interactions, and subcellular localization via techniques like Western blotting, immunoprecipitation, and immunofluorescence. Recent studies also explore DCTN3's non-canonical functions in nuclear processes, expanding its relevance beyond traditional cytoskeletal roles. As research progresses, DCTN3 antibodies continue to support investigations into both fundamental cell biology and disease mechanisms.
×
